About this trial
This observational study focuses on evaluating the effect of the current health care program for Danish children and adolescents with gender incongruence, which was established in January 2016. Somatic outcome parameters include growth, bone health, body composition, metabolic parameters, hormone levels and concurrent diseases. Psychosocial parameters include the trajectory of gender incongruence development, mental health, i.e. autism spectrum disorders, behavioural problems, self-harm, suicidal ideation and psychiatric diagnoses, and social context, i.e. family demographics, education, minority stress.
This study aims to:
1. Characterise the psychosocial profile of all children and adolescents referred for treatment, as well as the history of gender identity development and treatment trajectories. 2. Systematically evaluate biological parameters before and during hormonal treatment with gonadotropin-releasing hormone (GnRH) analogues and cross-sex hormones, and to establish a biobank for those in hormone treatment.
The investigators hypothesise that intervention with counselling and hormonal treatment is safe and has a positive impact on psychosocial well-being of transgender youngsters. The overall aim is to provide data for improving future family counselling, clinical care, patient satisfaction, patient safety and ultimately quality-of-life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Accepted referral to the gender identity service.
Disqualifiers
None.
Trial population
All children and youngsters under the age of 18 years referred to the gender identity service in Denmark.
Trial design
Cohort
Other
Treatments tested in this trial
Referral to the gender identity service.
Other interventionReferral to the national gender identity service consisting of the Sexological Clinic, Child and Adolescent Mental Health Center, and Department of Growth and Reproduction in the Capital Region of Denmark.
Treatment groups
Trial outcomes
Primary outcomes
Body Mass Index (BMI)
BMI will be calculated from height and weight (kg/m\^2) measurements
Puberty
Tanner stages of puberty (1-5) are obtained by clinical examination
Bone mineral content (BMD)
Whole body dual-energy x-ray absorptiometry (DXA) will determine BMD Z-score for age and sex
Body fat
Whole body dual-energy x-ray absorptiometry (DXA) will measure body fat percentage (%)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.